title: [Clinical effectiveness of nadroparin calcium in the surgical treatment of breast cancer].
abstract: The report deals with an assessment of frequency of fatal thromboembolic complications after surgery for breast cancer, in particular, frequency and severity of the side-effects of calcium nadroparin treatment as a component of surgical preparation. Considering the low incidence of thromboembolic complications in such patients and the side-effects of anti-coagulant therapy, it is suggested that decisions be made on a strictly individual basis under stringent clinical control.
authors.affiliation: A.A. Bogomolets National Medical University, Municipal Oncological Hospital, Kiev, Ukraine.
authors.forename: A Ia
authors.initials: AIa
authors.lastname: Iaremchuk
authors.forename: A S
authors.initials: AS
authors.lastname: Zotov
authors.forename: V E
authors.initials: VE
authors.lastname: Cheshuk
authors.forename: N F
authors.initials: NF
authors.lastname: Anikuc'ko
authors.forename: L M
authors.initials: LM
authors.lastname: Zakhartseva
authors.forename: M V
authors.initials: MV
authors.lastname: Diatel
authors.forename: A V
authors.initials: AV
authors.lastname: Kravchenko
authors.forename: O E
authors.initials: OE
authors.lastname: Lobanova
authors.forename: O I
authors.initials: OI
authors.lastname: Sidorchuk
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D008408:Mastectomy / Q000009:adverse effects*; D017762:Nadroparin / Q000627:therapeutic use*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D017762:Nadroparin